New isotretinoin warnings

Risks of sexual disorders and mood-related changes added to safety information for isotretinoin products  Health professionals are being urged to be alert to the possibility of psychiatric and sexual disorders in patients using severe cystic acne treatment, isotretinoin, originally sold as Roaccutane.  Following an investigation, the Therapeutic Goods Administration (TGA) issued an updated safety warning including: